Filing Details
- Accession Number:
- 0001103021-19-000039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-19 16:39:12
- Reporting Period:
- 2019-11-15
- Accepted Time:
- 2019-11-19 16:39:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1757833 | James Vollins | C/O Biodelivery Sciences Intl, Inc. 4131 Parklake Ave. Suite 225 Raleigh NC 27612 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-11-15 | 29,825 | $3.46 | 29,825 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-11-15 | 29,825 | $6.09 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (right to buy) | Disposition | 2019-11-15 | 29,825 | $0.00 | 29,825 | $3.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
59,651 | 2028-11-05 | No | 4 | M | Direct |
Footnotes
- The stock options were issued to the Reporting Person on November 5, 2018, pursuant to a grant under the Company's 2011 Equity Incentive Plan, as amended. The award is subject to time-based vesting and a third has vested on November 5, 2019. The remaining options vest in equal portions on:(i) November 5, 2020; and (ii) November 5, 2021.